NNOX
Get informed when a big investor buys or sells
+ FollowOvervalued by 710.8% based on the discounted cash flow analysis.
| Market cap | $59.85 Million |
|---|---|
| Enterprise Value | $23.63 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.16 |
| Beta | 1.27 |
| Outstanding Shares | 69,619,000 |
| P/E Ratio | -0.75 |
|---|---|
| PEG | -9.73 |
| Price to Sales | - |
| Price to Book Ratio | 0.86 |
| Enterprise Value to Revenue | 1.63 |
| Enterprise Value to EBIT | -0.39 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 0.06 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0966▲ 69.95% |
|---|---|
| Total Calls | 186,400▼ 72.80% |
| Total Puts | 204,400▼ 24.88% |
Holdings and activity of institutional investors.
| Ownership % | 13.88%▼ 11.84% |
|---|---|
| Total Invested | $11.22M▼ 72.43% |
| Investors Holding | 107▼ 26.00% |
No data
Nano-X Imaging Ltd operates as a medical imaging technology company. The Company offers cloud-based image analysis, online diagnosis, and billing services. Nano-X Imaging serves governments, hospitals, and clinic chains in Israel.